Dublin-(Business Wire)-"Brain monitoring market by product (equipment, MRI, CT, PET, EEG, EMG, MEG, TCD, ICP, electrode, solder paste, gel, battery, cable, infiltration) TBI, stroke, dementia, epilepsy, headache, sleep) and end users (hospitals, clinics, ASC)-global forecasts to 2025" report has been added to ResearchAndMarkets.com products.
By 2025, the global brain monitoring market is expected to grow from US$6.3364 billion in 2020 to US$8.5617 billion, with a compound annual growth rate of 6.2% during the forecast period.
Increasing incidence of neurological diseases and increasing awareness of neurodegenerative diseases will drive the brain monitoring market.
The brain monitoring market is mainly driven by the following factors: increasing incidence and prevalence of neurological diseases, increased awareness of neurodegenerative diseases, increasing number of traumatic brain injuries, and increasing application of brain monitoring in clinical trials.
The growing demand for non-invasive and minimally invasive devices, the continuous expansion of therapeutic applications of brain monitoring devices, and the growing healthcare market in emerging economies are also expected to provide growth opportunities for market participants. On the other hand, the high cost of complex brain monitoring programs and equipment, unfavorable reimbursement policies, and the lack of trained professionals to effectively operate brain monitoring equipment have limited the growth of this market.
The equipment segment is expected to occupy the largest share of the brain monitoring equipment market in 2019.
By product, the global brain monitoring market can be divided into equipment and accessories. It is expected that by 2019, the device segment will occupy the largest share of the brain monitoring market. This is mainly due to the increasing incidence of neurological diseases, neurodegenerative diseases, psychosis and sleep disorders; the need for early diagnosis; the availability of innovative portable and wearable home monitoring devices; and increasing patient awareness.
The electrode segment is expected to achieve the highest growth rate during the forecast period. Technological advancements have enhanced the tissue interface of electrodes and promoted the development of cost-effective, high-performance electrodes in this market. In addition, the introduction of disposable electrodes has greatly promoted its use and the growth of this market segment.
During the forecast period, North America will become the largest regional market in the brain monitoring market.
Based on this region, the global brain monitoring market is divided into North America, Europe, Asia and RoW. North America is expected to occupy the largest share of the global brain monitoring market in 2019, and Asia is expected to become the fastest growing region during the forecast period. The growth of the Asian market is attributed to the growth of the elderly population, the availability of cheap labor and skilled manpower, the increase in disposable income, the prevalence of neurodegenerative diseases, and the government's increasing emphasis on health care reform in the region.
The report is organized by region (Asia Pacific, Europe, North America and RoW), product (equipment and accessories), disease type (traumatic brain injury (TBI), stroke, dementia, headache, sleep disorder, Parkinson's disease, epilepsy, Huntington Diseases and other diseases), end users (entering hospitals, neurology centers, diagnostic centers, ASCs and clinics, and other end users). The report also provides a comprehensive overview of the market drivers, constraints and opportunities of the brain surveillance market.
The brain monitoring market is dominated by world-renowned companies, such as Natus Medical, Inc. (USA), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (USA), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), CAS Medical Systems, Inc. (USA), Drgerwerk AG & Co. KGaA (Germany), Advanced Brain Monitoring (USA), Masimo Corporation (USA), Spiegelberg GmbH & Co.KG (Germany), Cadwell Industries (United States), NeuroWave Systems, Inc. (United States), Nonin Medical, Inc. (United States), Integra LifeSciences Corporation (United States), Neurosoft (Russia) and Rimed (United States)
Post time: Sep-15-2020